My HPRA: Register

LAMIVUDINE TEVA PHARMA B.V.

300 Milligram Film Coated Tablet

Teva B.V.EU/1/09/596/8-14

Main Information

Trade NameLAMIVUDINE TEVA PHARMA B.V.
Active SubstancesLAMIVUDINE
Strength300 Milligram
Dosage FormFilm Coated Tablet
Licence HolderTeva B.V.
Licence NumberEU/1/09/596/8-14

Group Information

ATC CodeJ05AF05 Nucleoside and nucleotide reverse transcriptase inhibitors

Status

Authorised/WithdrawnAuthorised
Licence Issued10/12/2009
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back
Follow medicine

Print